DCP1A and diffuse large B-cell lymphoma: To further explore whether AGO2 is involved in the mRNA degradation of ouabain-treated DLBCL cells, we performed mRNA half-life on LSM1 and DCP1A, which were enriched in the RNA degradation pathway after treatment with ouabain.